MHA CEO Michael Herrera announced MHA was retained by a Fortune 12 Pharmacy innovation company to provide senior level BCM program augmentation services. “We are excited to provide our senior level expertise to augment the needs of an established BCM program”, said Michael Herrera CEO.
